These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

114 related articles for article (PubMed ID: 33638862)

  • 1. Reply to: Cohen and Ross: "Laser-Induced Chrysiasis: A Unique Adverse Event Associated with Q-Switched Lasers".
    Alster TS; Li MK
    Am J Clin Dermatol; 2021 Mar; 22(2):291. PubMed ID: 33638862
    [No Abstract]   [Full Text] [Related]  

  • 2. Laser-Induced Chrysiasis: A Unique Adverse Event Associated With Q-Switched Lasers.
    Cohen PR; Ross EV
    Am J Clin Dermatol; 2021 Mar; 22(2):289-290. PubMed ID: 33638861
    [No Abstract]   [Full Text] [Related]  

  • 3. Localized chrysiasis induced by laser therapy.
    Trotter MJ; Tron VA; Hollingdale J; Rivers JK
    Arch Dermatol; 1995 Dec; 131(12):1411-4. PubMed ID: 7492130
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Q-switched laser-induced chrysiasis treated with long-pulsed laser.
    Yun PL; Arndt KA; Anderson RR
    Arch Dermatol; 2002 Aug; 138(8):1012-4. PubMed ID: 12164737
    [No Abstract]   [Full Text] [Related]  

  • 5. Q-Switched Alexandrite Laser-induced Chrysiasis.
    Cohen PR; Ross EV
    J Clin Aesthet Dermatol; 2015 Sep; 8(9):48-53. PubMed ID: 26430491
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Laser induced chrysiasis: disfiguring hyperpigmentation following Q-switched laser therapy in a woman previously treated with gold.
    Almoallim H; Klinkhoff AV; Arthur AB; Rivers JK; Chalmers A
    J Rheumatol; 2006 Mar; 33(3):620-1. PubMed ID: 16511932
    [No Abstract]   [Full Text] [Related]  

  • 7. Development of chrysiasis after Q-switched ruby laser treatment of solar lentigines.
    Geist DE; Phillips TJ
    J Am Acad Dermatol; 2006 Aug; 55(2 Suppl):S59-60. PubMed ID: 16843130
    [No Abstract]   [Full Text] [Related]  

  • 8. Comparing the efficacy of pulsed dye laser, Q-Switched Nd-YAG, CO2, and combined CO
    Radmanesh M; Ghanatir F; Radmanesh R
    J Dermatolog Treat; 2021 Mar; 32(2):258-260. PubMed ID: 31415215
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Q-switched ruby laser treatment for postsclerotherapy hyperpigmentation.
    Tafazzoli A; Rostan EF; Goldman MP
    Dermatol Surg; 2000 Jul; 26(7):653-6. PubMed ID: 10886273
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Laser removal of tattoos.
    Kuperman-Beade M; Levine VJ; Ashinoff R
    Am J Clin Dermatol; 2001; 2(1):21-5. PubMed ID: 11702617
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Treatment of pigmentary disorders in patients with skin of color with a novel 755 nm picosecond, Q-switched ruby, and Q-switched Nd:YAG nanosecond lasers: A retrospective photographic review.
    Levin MK; Ng E; Bae YS; Brauer JA; Geronemus RG
    Lasers Surg Med; 2016 Feb; 48(2):181-7. PubMed ID: 26922302
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Laser treatment of imipramine-induced hyperpigmentation.
    Atkin DH; Fitzpatrick RE
    J Am Acad Dermatol; 2000 Jul; 43(1 Pt 1):77-80. PubMed ID: 10863228
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Effect of quality-switched laser exposure in patients with history of edible gold consumption.
    AlHargan A; AlTalhab S; Ghobara Y; Alissa A; AlJasser MI
    Lasers Med Sci; 2019 Dec; 34(9):1813-1817. PubMed ID: 30945021
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Cutaneous siderosis secondary to intramuscular iron dextran treated with 755 nm Q-switched alexandrite laser: A case report.
    Lloyd AA; Graves MS; Ross EV
    Lasers Surg Med; 2015 Jul; 47(5):386-7. PubMed ID: 25994768
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Low-fluence Q-switched Nd:YAG 1064-nm laser versus Q-switched Nd:YAG 532-nm laser in the treatment of hyperpigmented lips: a prospective, randomized, controlled, evaluator-blinded trial.
    Limpjaroenviriyakul N; Jurairattanaporn N; Kamanamool N; Rojhirunsakool S; Kanokrungsee S; Udompataikul M
    Lasers Med Sci; 2020 Feb; 35(1):165-171. PubMed ID: 31177406
    [TBL] [Abstract][Full Text] [Related]  

  • 16. 532 nm Q-switched laser for the treatment of hyperpigmentation induced by topical tacrolimus.
    Deilhes F; Konstantinou MP; Lamant L; Paul C; Hautier JM; Livideanu CB
    J Cosmet Laser Ther; 2020 Feb; 22(2):90-92. PubMed ID: 32202170
    [No Abstract]   [Full Text] [Related]  

  • 17. Comparing the efficacy and safety of Q-switched and picosecond lasers in the treatment of nevus of Ota: a systematic review and meta-analysis.
    Williams NM; Gurnani P; Long J; Reynolds J; Pan Y; Suzuki T; Alhetheli GI; Nouri K
    Lasers Med Sci; 2021 Jun; 36(4):723-733. PubMed ID: 32839837
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Lasers for treatment of melasma and post-inflammatory hyperpigmentation.
    Arora P; Sarkar R; Garg VK; Arya L
    J Cutan Aesthet Surg; 2012 Apr; 5(2):93-103. PubMed ID: 23060704
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Delayed darkening of imipramine-induced hyperpigmentation after treatment with a Q-switched Nd:YAG laser followed by a Q-switched ruby laser.
    Izikson L; Anderson RR
    Dermatol Surg; 2009 Mar; 35(3):527-9. PubMed ID: 19250303
    [No Abstract]   [Full Text] [Related]  

  • 20. Optimizing Q-switched lasers for melasma and acquired dermal melanoses.
    Aurangabadkar SJ
    Indian J Dermatol Venereol Leprol; 2019; 85(1):10-17. PubMed ID: 30027914
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.